The Cannabis Observer

ASX Cannabis and Biotech Quarterly Roundup: Avecho, Melodiol, Bioxyne, Emyria, Ecofibre, Zelira, Elixinol, AusCann and Botanix

The Cannabis Observer ·
ASX Cannabis and Biotech Quarterly Roundup: Avecho, Melodiol, Bioxyne, Emyria, Ecofibre, Zelira, Elixinol, AusCann and Botanix

Avecho Biotechnology will begin its low-dose CBD phase III clinical trial in the next two months […]

FOUNDING MEMBERS

First 100 readers lock in 50% off for life

Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.

  • Weekday briefings on regulation, access schemes, and the companies shaping the market
  • Full archive and weekly deep-dives once premium goes live
  • 50% off the launch price, locked in for as long as your subscription stays active

Join 87 readers already on the waitlist

Andrew Chapman AusCann Avecho Biotechnology Bioxyne BLS Botanix Pharmaceuticals CBD over the counter Dr Oludare Odumosu Ecofibre Elixinol Wellness Emyria Melodiol Global Health Merchant Group Paul Gavin Ron Dufficy Under Armour Zerila Therapeutics

Related Articles